Psychiatry and Neurology, Neurology · Palm Beach Gardens, FL
NPI
1891739488
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3401 Pga Blvd Ste 440
Palm Beach Gardens, FL, 33410
Phone (561) 799-2831
Groups this clinician bills Medicare through
Medicare paid, 2024
$508K
6,663 services
Medicare patients, 2024
1,287
Average age 80
Drug cost, 2024
$2.8M
4,424 prescriptions
Company payments, 2025
$3,289
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David S Silvers was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 2,470 times for 1,074 patients. In total David S Silvers billed 6,663 services in 33 codes, and Medicare paid $508K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,470 | 1,074 | $12.85 | $32K |
| 99214 Office E&M - Established | Office | 1,201 | 718 | $96.45 | $116K |
| 99215 Office E&M - Established | Office | 1,020 | 588 | $138.14 | $141K |
| 99205 Office E&M - New | Office | 411 | 411 | $172.79 | $71K |
| 96132 Behavioral Health Services | Office | 351 | 349 | $100.06 | $35K |
| 96136 Behavioral Health Services | Office | 339 | 338 | $32.41 | $11K |
| 99483 Office/Outpatient Services | Office | 201 | 201 | $204.82 | $41K |
| 95886 Electrical Nerve Conductivity | Office | 123 | 91 | $75.20 | $9,250 |
| 99213 Office E&M - Established | Office | 105 | 96 | $62.58 | $6,571 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 61 | 61 | $26.28 | $1,603 |
| 99204 Office E&M - New | Office | 46 | 46 | $126.07 | $5,799 |
| 95816 Neurologic | Office | 39 | 39 | $309.93 | $12K |
| 95910 Electrical Nerve Conductivity | Office | 23 | 23 | $138.37 | $3,182 |
| 95912 Electrical Nerve Conductivity | Office | 20 | 20 | $185.12 | $3,702 |
| 95909 Electrical Nerve Conductivity | Office | 15 | 15 | $100.63 | $1,510 |
By year: 2022 $479K for 4,118 services; 2023 $514K for 4,457 services; 2024 $508K for 6,663 services.
Medicare prescription drug claims, 2024
In 2024, the drug David S Silvers prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 440 prescriptions and refills. In total David S Silvers wrote 4,424 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 440 | 1,042 | 127 | $13K |
| Donepezil Hcl Generic | 337 | 763 | 117 | $4,552 |
| Gabapentin Generic | 253 | 483 | 72 | $5,544 |
| Escitalopram Oxalate Generic | 234 | 491 | 74 | $3,368 |
| Trazodone Hcl Generic | 214 | 462 | 78 | $2,159 |
| Rivastigmine Generic | 185 | 341 | 48 | $42K |
| Memantine Hcl Er Memantine Hcl | 178 | 267 | 37 | $9,973 |
| Memantine Hcl Generic | 152 | 358 | 43 | $8,491 |
| Pregabalin Generic | 143 | 230 | 35 | $4,131 |
| Duloxetine Hcl Generic | 135 | 248 | 40 | $3,719 |
| Sertraline Hcl Generic | 115 | 255 | 34 | $1,348 |
| Propranolol Hcl Generic | 95 | 198 | 27 | $1,811 |
| Rytary Carbidopa/Levodopa | 83 | 143 | 19 | $119K |
| Doxepin Hcl Generic | 73 | 141 | 29 | $3,324 |
| Quetiapine Fumarate Generic | 72 | 122 | 28 | $1,707 |
Brand drugs: 487 claims; generic drugs: 3,917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David S Silvers $3,289 ($3,289 in general payments such as food, travel and fees) from 28 companies. The largest payer was Neurocrine BioSciences, Inc. with $415.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 11 | $415 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $337 |
| Pfizer Inc. PFE | 11 | $278 |
| Amneal Pharmaceuticals LLC AMRX | 16 | $275 |
| Janssen Biotech, Inc. JNJ | 6 | $239 |
| Abbvie Inc. ABBV | 12 | $238 |
| Neurelis, Inc. | 7 | $202 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $121 |
| Lundbeck LLC | 4 | $119 |
| Lilly USA, LLC LLY | 4 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.